VSEE HEALTH, INC. Files 8-K with Bylaw Amendments

TL;DR

VSEE HEALTH files 8-K: Bylaw changes & financials updated. Check for governance shifts.

AI Summary

VSEE HEALTH, INC. filed an 8-K on December 18, 2025, reporting events as of December 17, 2025. The filing indicates amendments to its Articles of Incorporation or Bylaws and includes financial statements and exhibits. The company, formerly known as DIGITAL HEALTH ACQUISITION CORP., is incorporated in Delaware and has its principal business address in Boca Raton, Florida.

Why It Matters

This 8-K filing signals potential corporate governance changes or the inclusion of important financial disclosures for VSEE HEALTH, INC., which could impact investor understanding of the company's structure and performance.

Risk Assessment

Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant negative news or events.

Key Players & Entities

• VSEE HEALTH, INC. (company) — Registrant
• December 17, 2025 (date) — Earliest event reported
• December 18, 2025 (date) — Filing date
• DIGITAL HEALTH ACQUISITION CORP. (company) — Former company name
• Delaware (jurisdiction) — State of incorporation
• Boca Raton, Florida (location) — Business address

FAQ

Key Financial Figures

• $0.0001 — e on which registered Common Stock, $0.0001 par value per share VSEE The Nasdaq
• $11.50 — (1) share of common stock at a price of $11.50 per whole share VSEEW The Nasdaq St

Filing Documents

• vsee8k121725.htm (8-K) — 41KB
• vseeex3-1.htm (EX-3.1) — 10KB
• 0001185185-25-002102.txt ( ) — 260KB
• vsee-20251217.xsd (EX-101.SCH) — 4KB
• vsee-20251217_def.xml (EX-101.DEF) — 26KB
• vsee-20251217_lab.xml (EX-101.LAB) — 36KB
• vsee-20251217_pre.xml (EX-101.PRE) — 25KB
• vsee8k121725_htm.xml (XML) — 6KB

From the Filing

UNITED SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 17, 2025 VSEE HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-41015 86-2970927 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 980 N Federal Hwy #304 Boca Raton , Florida 33432 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: ( 561 ) 672-7068 N/A (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Title of each class Trading Symbol Name of each exchange on which registered Common Stock, $0.0001 par value per share VSEE The Nasdaq Stock Market LLC Warrants, which entitles the holder to purchase one (1) share of common stock at a price of $11.50 per whole share VSEEW The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933(230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On December 17, 2025, the Board of Directors of VSee Health, Inc. (the "Company") approved an amendment of the Company's Bylaws to reduce the quorum needed for stockholder meetings to one-third (33.33%) of the voting power of the shares of capital stock of the Company issued and outstanding and entitled to vote at a meeting of stockholders, present in person or represented by proxy. The quorum requirement was also applied retroactively to the 2025 Annual Meeting of Stockholders (the "Annual Meeting"). The Annual Meeting will be held on December 30, 2025, beginning at 2:30 p.m. eastern time via live webcast at the following address: https://www.cstproxy.com/vseehealth/2025. Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 3.1 Amendment No. 1 to the Amended and Restated Bylaws of VSee Health, Inc. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. Dated: December 18, 2025 VSEE HEALTH, INC. By: /s/ Milton Chen Name: Milton Chen Title: Co-Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR